Methylprednisolone - acute spinal cord injury, benefits or risks?

被引：0

作者：

Tesiorowski, Maciej ^{[1
]}

Potaczek, Tomasz ^{[1
]}

Jasiewicz, Barbara ^{[1
]}

Sapa, Jacek ^{[2
]}

Zygmunt, Malgorzata ^{[2
]}

机构：

[1] Uniwersytetu Jagiellonskiego, Katedra & Klin Ortopedii & Rehabil Zakopanem, Coll Med, PL-30688 Krakow, Poland

[2] Uniwersytetu Jagiellonskiego, Zaklad Wstepnych Badan Farmakol, Katedry Farmakodynamiki, Coll Med, PL-30688 Krakow, Poland

来源：

POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ | 2013年 / 67卷

关键词：

methylprednisolone; acute spinal cord injury; inflammatio; neuroprotection; HIGH-DOSE METHYLPREDNISOLONE; EFFICACY; STEROIDS; NALOXONE;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Methylprednisolone is a synthetic glucocorticoid with a potent and long-acting anti-inflammatory, antiallergic and immunosuppressant. Its mechanism of action of methylprednisolone is the result of many cellular changes. Methylprednisolone is used in many diseases, such as rheumatic diseases, autoimmune diseases, allergic, anaphylactic shock, asthma. Methylprednisolone was also used in patients with spinal cord injury, in order to minimize neurological damage. While in the above mentioned fields of medicine is undeniable role of methylprednisolone, whereas its use in the treatment of traumatic spinal cord injury within the last few years raises a lot of controversy, and in most cases, the side effects of its use outweigh the potential benefits.

引用

页码：601 / 609

页数：9

共 50 条

[1] The Use of Methylprednisolone in Acute Spinal Cord Injury A Review of the Evidence, Controversies, and Recommendations
Breslin, Kristen
Agrawal, Dewesh
PEDIATRIC EMERGENCY CARE, 2012, 28 (11) : 1238 - 1248
[2] Methylprednisolone and acute spinal cord injury - An update of the randomized evidence
Bracken, MB
SPINE, 2001, 26 (24) : S47 - S54
[3] Effect of Methylprednisolone and Edaravone administration on spinal cord injury
Wang, J.
Guo, G.
Wang, W.
Tang, Y.
Shun, J.
Zhou, X.
Zhang, P.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (20) : 2766 - 2772
[4] Current Role of Methylprednisolone in the Treatment of Acute Spinal Cord Injury
Lukas, R.
Zykova, I.
Barsa, P.
Sram, J.
ACTA CHIRURGIAE ORTHOPAEDICAE ET TRAUMATOLOGIAE CECHOSLOVACA, 2011, 78 (04) : 305 - 313
[5] Current use of methylprednisolone for acute spinal cord injury in Poland: Survey study
Miekisiak G.
Kloc W.
Janusz W.
Kaczmarczyk J.
Latka D.
Zarzycki D.
European Journal of Orthopaedic Surgery & Traumatology, 2014, 24 (Suppl 1) : S269 - S273
[6] Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
Christian A.Bowers
Bornali Kundu
Gregory W.J.Hawryluk
Neural Regeneration Research, 2016, 11 (06) : 882 - 885
[7] Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
Bowers, Christian A.
Kundu, Bornali
Hawryluk, Gregory W. J.
NEURAL REGENERATION RESEARCH, 2016, 11 (06) : 882 - 885
[8] Changes in the Use of the Methylprednisolone Protocol for Traumatic Spinal Cord Injury in Switzerland
Felleiter, Peter
Mueller, Nicole
Schumann, Frederik
Felix, Olga
Lierz, Peter
SPINE, 2012, 37 (11) : 953 - 956
[9] Current Practice of Methylprednisolone Administration for Acute Spinal Cord Injury in Germany A National Survey
Druschel, Claudia
Schaser, Klaus-Dieter
Schwab, Jan M.
SPINE, 2013, 38 (11) : E669 - E677
[10] Methylprednisolone in acute spinal cord injuries
PA O’Connor
O McCormack
C Gavin
R Dungan
C Kirke
D McCormack
J O’Byrne
M Stephens
F McManus
M Walsh
Irish Journal of Medical Science, 2003, 172 : 24 - 26

← 1 2 3 4 5 →